Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3004478rdf:typepubmed:Citationlld:pubmed
pubmed-article:3004478lifeskim:mentionsumls-concept:C1801960lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C1882561lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C0020291lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C0031621lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C0243127lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C0031586lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C1704666lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C1517892lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C0208973lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C0443331lld:lifeskim
pubmed-article:3004478lifeskim:mentionsumls-concept:C1140999lld:lifeskim
pubmed-article:3004478pubmed:issue2lld:pubmed
pubmed-article:3004478pubmed:dateCreated1986-3-24lld:pubmed
pubmed-article:3004478pubmed:abstractTextWe investigated the actions of two biologically active phorbol esters, phorbol dibutyrate (PDB) and phorbol myristate acetate (PMA), on receptor-stimulated phosphoinositide hydrolysis in rat aorta. We found both PDB and PMA potently inhibited norepinephrine (NE) stimulated PI hydrolysis in rat aortic rings. The biologically inactive phorbol, 4-alpha-phorbol was ineffective. In the presence of the calcium channel antagonist nitrendipine, PDB potently inhibited both the phasic and tonic components of NE-induced contraction. These results suggest a functional coupling between receptor-stimulated PI turnover and vascular contraction. They also suggest a mode of feed-back regulation in vascular tissue involving phorbol esters in receptor-stimulated PI hydrolysis.lld:pubmed
pubmed-article:3004478pubmed:languageenglld:pubmed
pubmed-article:3004478pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3004478pubmed:citationSubsetIMlld:pubmed
pubmed-article:3004478pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3004478pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3004478pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3004478pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3004478pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3004478pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3004478pubmed:statusMEDLINElld:pubmed
pubmed-article:3004478pubmed:monthJanlld:pubmed
pubmed-article:3004478pubmed:issn0006-291Xlld:pubmed
pubmed-article:3004478pubmed:authorpubmed-author:ChernowBBlld:pubmed
pubmed-article:3004478pubmed:authorpubmed-author:McMillanMMlld:pubmed
pubmed-article:3004478pubmed:authorpubmed-author:RothB LBLlld:pubmed
pubmed-article:3004478pubmed:issnTypePrintlld:pubmed
pubmed-article:3004478pubmed:day29lld:pubmed
pubmed-article:3004478pubmed:volume134lld:pubmed
pubmed-article:3004478pubmed:ownerNLMlld:pubmed
pubmed-article:3004478pubmed:authorsCompleteYlld:pubmed
pubmed-article:3004478pubmed:pagination970-4lld:pubmed
pubmed-article:3004478pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:meshHeadingpubmed-meshheading:3004478-...lld:pubmed
pubmed-article:3004478pubmed:year1986lld:pubmed
pubmed-article:3004478pubmed:articleTitlePhorbol esters inhibit alpha 1-adrenergic receptor-stimulated phosphoinositide hydrolysis and contraction in rat aorta: evidence for a link between vascular contraction and phosphoinositide turnover.lld:pubmed
pubmed-article:3004478pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3004478pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:3004478pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3004478lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3004478lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3004478lld:pubmed